Status:
COMPLETED
Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen
Lead Sponsor:
Bispebjerg Hospital
Collaborating Sponsors:
ALK-Abelló A/S
Conditions:
Allergic Rhinitis Due to Grass Pollens
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Treatment of pollen allergies can be roughly divided into symptomatic treatment (e.g. antihistamines, steroids) and potentially curative immunotherapy. Immunotherapy can be delivered using subcutaneou...
Detailed Description
Worldwide, more than 400 million people have allergic rhinitis, and sick-leave due to this condition costs societies billions of dollars annually1. Allergic rhinitis is most commonly treated with oral...
Eligibility Criteria
Inclusion
- history of rhinitis with hay fever symptoms during the grass pollen season,
- a skin-prick-test-verified grass pollen allergy (Phleum pratense),
- eligibility for immunotherapy based on ARIA guidelines
Exclusion
- current long-term systemic steroid treatment,
- previous immunotherapy,
- asthma and outside-season airway hyperresponsiveness (AHR) (September 2011),
- pregnancy,
- negative RAST for grass, and
- treatment side effect
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01889875
Start Date
November 1 2010
End Date
August 1 2012
Last Update
July 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg University Hospital
Copenhagen NV, Denmark, Denmark, 2400